During the past decade, Center Hospital of the National Center for Global Health and Medicine conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 22 clinical trials were completed, i.e. on average, 43.1% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 19 clinical trials were completed. i.e. 57.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center Hospital of the National Center for Global Health and Medicine" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Boehringer Ingelheim" with 9 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Janssen Pharmaceutical K.K." with 4 trials sponsored and "National Center for Global Health and Medicine, Japan" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center Hospital of the National Center for Global Health and Medicine" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Center Hospital of the National Center for Global Health and Medicine" are "COVID-19" (6 trials), "Idiopathic Pulmonary Fibrosis" (6 trials), "Schizophrenia" (5 trials), "Ulcerative Colitis" (3 trials) and "AIDS" (2 trials). Many other conditions were trialed in "Center Hospital of the National Center for Global Health and Medicine" in a lesser frequency.

Most popular intervention types in "Center Hospital of the National Center for Global Health and Medicine" are "Drug" (55 trials), "Other" (11 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Remdesivir" (4 trials), "Mirikizumab" (3 trials), "Baricitinib" (2 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Center Hospital of the National Center for Global Health and Medicine" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Center Hospital of the National Center for Global Health and Medicine". undefined are not yet recruiting, 16 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Center Hospital of the National Center for Global Health and Medicine, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Center Hospital of the National Center for Global Health and Medicine, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".